Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Pedvaxhib Generic Name & Formulations
Legal Class
Rx
General Description
Haemophilus b conjugate 7.5mcg (meningococcal protein conjugate 250mcg); per 0.5mL; IM inj.
Pharmacological Class
Hib (PRP-OMP).
How Supplied
Single-dose vials (w. diluent)—10
Manufacturer
Pedvaxhib Indications
Indications
Immunization of children against H. influenzae type b.
Pedvaxhib Dosage and Administration
Children
<2 months: not recommended. 2 and 4 months: 0.5mL lM. Children vaccinated (with 2 dose regimen) before 12 months should receive booster at 12 months (but not <2 months after previous shot). Previously unvaccinated children, 15–71 months: 0.5mL lM once.
Pedvaxhib Contraindications
Contraindications
Aluminum allergy.
Pedvaxhib Boxed Warnings
Not Applicable
Pedvaxhib Warnings/Precautions
Warnings/Precautions
Immunodeficiency. Delay administration in febrile or active infection. Have epinephrine inj (1:1000) available. Protection begins several days after injection. Pregnancy (Cat. C): not recommended.
Pedvaxhib Pharmacokinetics
See Literature
Pedvaxhib Interactions
Pedvaxhib Adverse Reactions
Adverse Reactions
Local reactions, fever.
Pedvaxhib Clinical Trials
See Literature
Pedvaxhib Note
Not Applicable
Pedvaxhib Patient Counseling
See Literature
